Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Early and Sustained Elevation in Serum Pancreatic Amylase Activity: A Novel Predictor of Morbidity After Pancreatic Surgery

Title: Early and Sustained Elevation in Serum Pancreatic Amylase Activity: A Novel Predictor of Morbidity After Pancreatic Surgery
Authors: Bannone, Elisa; Marchegiani, Giovanni; Balduzzi, Alberto; Procida, Giuseppa; Vacca, Pier Giuseppe; Salvia, Roberto; Bassi, Claudio
Contributors: Bannone, Elisa; Marchegiani, Giovanni; Balduzzi, Alberto; Procida, Giuseppa; Vacca, Pier Giuseppe; Salvia, Roberto; Bassi, Claudio
Publication Year: 2023
Collection: Università degli Studi di Verona: Catalogo dei Prodotti della Ricerca (IRIS)
Subject Terms: postoperative hyperamylasemia; postpancreatectomy acute pancreatitis; serum amylase trend
Description: Objective:To characterize early postoperative serum pancreatic amylase (spAMY) trends after pancreatic resections. Summary Background Data:A postoperative spAMY elevation is a common finding but uncertainties remain about its meaning and prognostic implications. Methods:Analysis of patients who consecutively underwent pancreatectomy from 2016 to 2019. spAMY activity was assessed from postoperative day (POD) 0 to 3. Different patterns of spAMY have been identified based on the spAMY standard range (10-52 U/l). Results:Three patterns were identified: (#1) spAMY values always < the lower limit of normal/within the reference range /a single increase in spAMY > upper limit of normal at any POD; (#2) Sustained increase in spAMY activity on POD 0 + 1; (#3) Sustained increase in spAMY activity including POD 1 + 2. Shifting through spAMY patterns was associated with increase morbidity (21% in #1 to 68% in #3 at POD 7; log rank < 0.001). Almost all severe complications (at least Clavien-Dindo >= 3) occurred in patients with pattern #3 (15% vs 3% vs 5% in #1 and #2 at POD 7, P = 0.006), without difference considering >3-times or >the spAMY normal limit (P = 0.85). POPF (9% in #1 vs 48% in #3, P < 0.001) progressively increased across patterns. Pre-operative diabetes (OR 0.19), neoadjuvant therapy (OR 0.22), pancreatic texture (OR 8.8), duct size (OR 0.78), and final histology (OR 2.2) were independent predictors of pattern #3. Conclusions:A sustained increase in spAMY activity including POD 1 + 2 (#3) represents an early postoperative predictor of overall and severe early morbidity. An early and dynamic evaluation of spAMY could crucially impact the subsequent clinical course with relevant prognostic implications.
Document Type: article in journal/newspaper
Language: English
Relation: info:eu-repo/semantics/altIdentifier/pmid/33938491; info:eu-repo/semantics/altIdentifier/wos/WOS:000905219700038; volume:277; issue:1; firstpage:N/A; lastpage:N/A; numberofpages:N/A; journal:ANNALS OF SURGERY; https://hdl.handle.net/11562/1108947
DOI: 10.1097/SLA.0000000000004921
Availability: https://hdl.handle.net/11562/1108947; https://doi.org/10.1097/SLA.0000000000004921
Rights: info:eu-repo/semantics/openAccess ; license:Dominio pubblico ; license uri:http://creativecommons.org/publicdomain/zero/1.0/
Accession Number: edsbas.CF06C2E2
Database: BASE